Company profile
Earth Science Tech, Inc.
OTC: ETST · Healthcare · Drug Manufacturers - Specialty & Generic
#479 of 1,418 Healthcare companies by revenue53rd-percentile growth
EA Score
69BFH 89DQ 51GM 51SS 57
v0.1 · 65/100 weight · provisional
↑ 3-yr revenue growth, return on assets · ↓ growth stability, filing timeliness
Methodology →Revenue TTM
$35.7M
Rev growth YoY (TTM)
+7.8%
Net income (FY)
$3.6M
Employees
77
as of 2026-08-20
Market cap
$31.7M
as of 2026-08-20
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$35.7M$35.7M2026
Net income$3.6M$3.6M2026
Operating income$892.3k$892.3k2024
Total assets$9.0M$9.0M2026
Liabilities$1.9M$1.9M2026
Equity$7.0M$7.0M2026
Revenue trend
FY2019 – FY2026 · USD
FY19
FY20
FY21
FY22
FY23
FY25
FY25
FY26
Revenue by segment
Filed disclosures · FY2025
By product
Shipping and Handling89%
Other Revenue11%
By geography
Not disclosed.
The read
What is Earth Science Tech, Inc.’s revenue?
Earth Science Tech, Inc. booked $35.7M in FY2026 revenue, growing 7.8% year over year — about the middle of the pack among Healthcare companies we track, at a 10.2% net margin.
Peers · Healthcare
ClearPoint Neuro, Inc.62CSunshine Biopharma, Inc.50DC4 Therapeutics, Inc.49DVerrica Pharmaceuticals Inc.51DLeef Brands Inc.57CSenseonics Holdings, Inc.57CNeighbors
Miami-Dade →Key facts
CEOGiorgio R. Saumat
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersMiami, FL
ExchangeOTC: ETST
Employees77
IPO date2014-01-15
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.